United States-based STI Pharma LLC announced yesterday that it has named Frank Mullery as its new president and CCO.
Mullery has more than 15 years of experience in the pharmaceutical industry, most recently serving as the president, Institutional Business at Mylan Inc, from 2016 to 2019. Prior to this, Mullery was CFO of North America for Mylan and has held roles of increasing scope and complexity in both the commercial and financial functions for Teva Pharmaceuticals and Viropharma Inc.
In his new role at STI Pharma, he will report directly to Anup Dam, chairman and manager of STI Pharma.
CSOFT Health Sciences executive named new regional chair of DIA's India Medical Writing Community
INOVIO names new president of INOVIO Asia and SVP, Clinical Development
Moderna and Catalent Team for Fill-Finish Manufacturing of Moderna's COVID-19 Vaccine Candidate
Akeso names new lead gynecologic oncology advisor and chair of the Steering Committee
Therapeutics Solutions International plans to use StemVacs for COVID-19 patient treatment
Clover Biopharmaceuticals Initiates Phase 1 Clinical Trial for COVID-19 Vaccine Candidate
Akebia Therapeutics names new SVP, CFO and treasurer
Epsilen Bio Names Berretta as Chief Executive Officer and Simon as Chairman of the Board
CANbridge Pharmaceuticals appoints Carrie Ann Cook new SVP/global head of Business Development